key: cord-0838712-6auk1jng
authors: Keskin, Halil; Keskin, Filiz; Yildirim, Elif; Saritas, Serdar; Polat, Gokhan; Colak, Abdurrahim; Laloglu, Fuat; Guler, Muhammet Akif; Ozay, Mustafa; Alp, Handan
title: Case of Venous Thromboembolia Under Enoxaparin Prophylaxis After Recovering From Acute Ischemic Stroke in Consequence of COVID-19-Related MIS-C
date: 2022-02-10
journal: Pediatr Infect Dis J
DOI: 10.1097/inf.0000000000003488
sha: 3f404eb02bf4c73bcade230724c6bf7c14dd7a46
doc_id: 838712
cord_uid: 6auk1jng

nan

Body temperature was 38.1°C, oxygen saturation 94%, respiratory rate 45 breaths and heart rate 144 beats per minute, blood pressure 85/45mmHg after norepinephrine, Glasgow coma scale was 13-points, with physical examination notable for leftsided hemiparesis (1/5 muscle strengths) and central facial paralysis, increased patellar deep tendon reflexes and left positive Babinski sign, erythematous plantar areas, and nonpurulent conjunctivitis.

Blood tests revealed a systemic hyperinflammatory state. COVID-19 nucleocapid Ig M and Ig G were positive. Brain magnetic resonance imaging with diffusionweighted showed that exhibit restricted diffusion at the level of the right temporal lobe and Sylvian cortex (Fig. 1) . Transthoracic echocardiogram demonstrated a left ventricular ejection fraction of 51% with global strain and mild mitral valve regurgitation. The thrombophilia panel result was normal. Doppler ultrasonography was negative for deep venous thrombosis.

He was diagnosed with MIS-C based on the World Health Organization and Centers for Disease Control and Prevention criteria and treated with intravenous immunoglobulin, intravenous methylprednisolone, subcutaneous enoxaparin, and oral aspirin.

Progressive resolution of the systemic hyperinflammatory state occurred within 48-72 hours. He was discharged with prophylactic enoxaparin treatment (100 IU/ kg-daily) with independence in all activities of daily living end of 14 day. On day 28 outpatient follow-up, the physical examination was normal except for mild left-sided central facial paralysis. After about a week, he was readmitted to the hospital due to swollen right upper limb without pain and tenderness. The linear swelling and reddish discoloration occurred on the median antebrachial vein trace ( Fig. 2A) . Because of the clinical suspicion of thrombosis, venous doppler ultrasonography was performed and showed absent flow at the level of this vein (Fig. 2B) . All other venous system examinations, transthoracic echocardiogram and brain magnetic resonance imaging angiography showed no abnormalities. Blood tests include hyperinflammatory and thrombosis markers were within the normal range. Enoxaparin treatment was readjusted to 100 IU/kg-twice daily.

We describe the first case of MIS-C related acute ischemic stroke with venous thromboembolism while under enoxaparin prophylaxis after recovery from MIS-C in a child with no underlying disease. We suggest that aggressive therapy to halt the cytokine storm and appropriate supportive care while considering differential diagnosis is crucial for reaching positive outcomes in children. It should be kept in mind that pediatric patients treated for MIS-C should be followed closely in terms of thromboembolism risk even if they receive anticoagulant therapy.

Novel coronavirus, Wuhan, China. Information for Healthcare Professionals

Novel Coronavirus (2019-nCoV) technical guidance

Overcoming COVID-19 Investigators. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome

Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C

Thrombotic risk in children with COVID-19 infection: a systematic review of the literature

Hypointense signals in the ADC (A) mapping and hyperintense signals in the B1000 diffusion sequence (B) were observed at the level of the right temporal lobe and Sylvian cortex (Circles), in the patient's first magnetic resonance imaging. ADC indicates adherent diffusion coefficient. Large studies have proven that coronavirus disease 2019 (COVID-19) can cause, in severe cases, thrombotic complications in adults. 1 However, these hematologic disorders have been so far exceptional in children with the last predominant virus variants. 2, 3 Since the beginning of the pandemic, only 4 cases of venous thrombosis have been reported in Spain in children with SARS-CoV-2 infection. 2 Two of these children associated several significant thrombotic risk factors, and the other 2 were female teenagers, one of whom had lupus anticoagulants. Nevertheless, since the emergence of the Omicron variant, 2 new cases of thrombosis, in a 7-and 11-year-old healthy boys were recorded in our country in December 2021.In these 2 new cases, severe cerebral venous sinus thrombosis occurred in relation with a concomitant complicated sinusitis, requiring both of them intensive care unit admission at diagnosis. In the case of the 7-year-old patient, cavernous sinus and both internal jugular veins were affected (Fig. 1) . The oldest patient presented a superior sagittal sinus thrombosis (Fig. 2) . Both patients had a close contact with a COVID-19 case and a positive SARS-CoV-2 reverse